genedrive plc (LON:GDR – Get Free Report)’s share price traded down 1.2% during mid-day trading on Monday . The company traded as low as GBX 0.85 and last traded at GBX 0.89. 1,822,853 shares traded hands during mid-day trading, a decline of 33% from the average session volume of 2,722,489 shares. The stock had previously closed at GBX 0.90.
genedrive Trading Down 2.1%
The company has a debt-to-equity ratio of 0.35, a current ratio of 4.60 and a quick ratio of 5.52. The firm’s 50 day moving average price is GBX 0.92 and its 200 day moving average price is GBX 0.83. The stock has a market capitalization of £11.84 million, a P/E ratio of -1.28 and a beta of -0.04.
About genedrive
ggenedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms. Based in the UK, the Company is at the forefront of Point of Care pharmacogenetic testing in emergency healthcare.
See Also
- Five stocks we like better than genedrive
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- A U.S. “birthright” claim worth trillions – activated quietly
- Executive Order 14330: Trump’s Biggest Yet
Receive News & Ratings for genedrive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for genedrive and related companies with MarketBeat.com's FREE daily email newsletter.
